Gathering data on hepatomiR for liver disease outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on hepatomiR, a CE-certified test designed to assess liver-related outcomes in patients with chronic liver disease. The focus is on defining a cut-off for specific decompensation events such as ascites, variceal hemorrhage, and hepatic encephalopathy. By analyzing these data, the study seeks to enhance the understanding of factors that contribute to liver decompensation, which could inform future risk management and therapeutic strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Chronic liver disease (more than 6 months)
* LSM ≥ 10 kPa
* Outpatient at the Clinical Department of Internal Medicine II, University Hospital St. Pölten
* Signed patient consent form

Exclusion Criteria:

* Age older than 18 years
* Pregnancy
* Primary hepatic malignancy (hepatocellular carcinoma, cholangiocarcinoma) with portal invasion and/or extrahepatic spread

Where it's running

• University Hospital St. Pölten
  Sankt Pölten, Lower Austria, Austria Recruiting

Study contacts

• Principal investigator: Andreas Maieron, PD Dr. — Karl Landsteiner University of Health Sciences
• Study coordinator: Lukas Erhart, Mag. Dr.
• Email: lukas.erhart@stpoelten.lknoe.at
• Phone: 00432742900412311

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endohepatology-based reclassification of treatment indication in high-risk MASLD

  This study tests whether an endohepatology assessment can change treatment decisions for adults with high-risk MASLD.

  Recruiting University Hospital Muenster · Münster · NCT07877272

• Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

  A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

  Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

• Magnetic Resonance Cholangiopancreatography to help living liver donors and their recipients

  This study tests whether preoperative MRCP imaging can help select living liver donors and reduce biliary complications in recipients.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07715500

• Genetic factors in graft fatty liver after living-donor liver transplant

  This study will see if donor and recipient genetic variants, especially PNPLA3 and MBOAT7, are linked to fat buildup in the transplanted liver among adults who had living-donor liver transplants for MAFLD-related cirrhosis.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07685353

• Austrian PBC Registry

  This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.

  Recruiting Medical University of Vienna · Klagenfurt, Carinthia and 10 other locations · NCT07598669

• 4D-Flow MRI to see portal hypertension and TIPS outcomes in cirrhosis

  This study tests a noninvasive 4D-Flow MRI method to see if it can safely and reliably reflect portal hypertension and predict outcomes for people with cirrhosis, including those needing a TIPS procedure.

  Recruiting at 2 sites Assistance Publique - Hôpitaux de Paris · Paris and 1 other locations · NCT07554183

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.